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Abstract
Neural abnormalities commonly associated with autism spectrum disorders
include prefrontal cortex (PFC) dysfunction and cerebellar pathologies in the form of
Purkinje cell loss and cerebellar hypoplasia. It has been shown that cerebellar Purkinje
cell loss and dysfunction results in abnormal dopamine neurotransmission in the PFC.
With use of a mouse model, we explored the effects of Purkinje cell loss on the
disruption of glutamatergic projections to the PFC that ultimately influences dopamine
(DA) release. Glutamate release was evoked by localized electrical stimulation coupled
with fixed potential amperometry in combination with a glutamate selective enzymebased recording probe in urethane anesthetized Lurcher mutant and wildtype mice. The
results indicated, in comparison to wildtype mice, evoked glutamate release was reduced
in Lurcher mutants. These results are consistent with the hypothesis that developmental
loss of cerebellar Purkinje cells directly influences evoked glutamate release in cerebellar
efferent pathways that ultimately influences PFC DA.
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Glutamate Dysfunction Associated with Developmental
Cerebellar Damage: Relevance to Autism Spectrum Disorders
Autism spectrum disorders (ASD). ASD are a group of neurodevelopmental
disorders that affects 1 out of every 68 children (CDC, 2014). This is over a two-fold
increase in prevalence rates over a 10 year span. ASD is comprised of autism, Asperger’s
syndrome, and pervasive developmental disorders not otherwise specified (APA, 2013).
Disorders within the spectrum of ASD primarily consist of social and cognitive deficits,
often characterized by poor social skills, communication, strange and repetitive
behaviors, as well as many others (CDC, 2014; APA, 2013; Ozonoff et al., 2010; Rogers
& DiLalla, 1990). Cognitive deficits that manifest within individuals with autism range
from poor theory of mind, executive function and planning, rule acquisition, abstract
thinking, and cognitive flexibility (Ozonoff, South, & Provencal, 2007). ASD is generally
diagnosed around 4.8 years of life, with symptoms suggesting social and cognitive
impairment connected with autism as young as 6 months of age (APA, 2013; CDC, 2014;
Ozonoff et al., 2010; Rogers & DiLalla, 1990; Wolff et al., 2012).
Etiology of Autism
The etiology of ASD is very diverse, much like several other mental health issues,
with various influences from genetic factors to prenatal and perinatal environments and
exposures. According to studies exploring concordance rates in twins, the heritability of
autism is approximately 60-90% (Bailey et al., 1995; Hallmayer et al., 2011). Studies
evaluating the contribution of genetics have found that multiple genes, upwards of 20,
contribute to the disorder (Muhle, Trentacoste, & Rapin 2004; Risch, Spiker, Lotspeich,
Nouri, & Hinds, 1999). Cytogenetic studies have found chromosomal abnormalities in
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regions such as 15q and 7q as well as whole-genome scans implicate chromosomes
1,2,4,7,10,130,15,16,17,19,22 and X (Campbell et al., 2006; Dimitropoulos & Schultz,
2007; Muhle et al., 2004; Schanen, 2006). More detailed exploration is critical in
identifying the exact genetic influence of the aforementioned chromosomes, as the known
genetic variations only account for approximately 5-15% of cases (Devlin & Schere,
2012). This small percentage is insufficient to account for the entire etiological scope of
autism.
Prenatal and perinatal environment influences as well as possible teratogens are
believed to be a precursor to autism. The developing brain is extremely plastic and
susceptible to a wide range of detrimental influences early in development, prenatally,
perinatally, and neonatally. Complications of gestational carrying and/or labor, such as
hyperbilirubinemia, induction of labor, prolonged labor, cerebral hypoxia as well as
others are often preceding factors of autism (Deykin & MacMahon, 1980; Gilberg &
Gilberg, 1983; Finegan & Quarrington, 1979; Jull-Dam, Townsend, & Courchesne 2001).
Exposure to certain chemicals, such as ethyl alcohol, thalidomide, misoprostol, and
valproic acid have been shown specifically to result in autistic symptoms as well as
increased likelihood in a diagnosis of autism (Bandim, Ventura, Miller, Almedia, &
Costa, 2003; Landrigan, 2010; Moore et al., 2000; Rodiger, 2002). Brimberg and
colleagues (2013), believe that autoimmune disorders in mothers is often a precursor for
her child to later be diagnosed with autism. Despite clear evidence of the effects such
teratogens have on a vulnerable life, the relative influence, much like genetic factors, is
fairly minimal. Due to the small influences of genetic and prenatal and perinatal
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influences that have been evaluated there is likely a much larger, unknown, synergism of
genetic predisposition and environmental interactions.
Despite a void in clear understanding of the etiology of autism, there are distinct
and common neuropathological abnormalities present in individuals with autism.
Neuropathological abnormalities primarily present in the cerebellum. Cerebellar deficits
are found postmortem in approximately 95 % of cases of individuals with autism as
compared to healthy individuals, via autopsy (Allen, Muller, & Courchesne, 2004). The
cerebellum has traditionally been associated primarily with motor function, however
recently there has been much evidence to show that it plays major roles in cognitive
functions as well (Schmahmann & Caplan, 2006). The cerebellum is structurally and
functionally abnormal in individuals diagnosed with ASD (Fatemi et al., 2012). This
supports additional evidence that cognitive deficits may be due to the physiological
abnormalities in the cerebellum.
Cerebellar neuropathology commonly occurs in individuals with autism, with
cerebellar hypoplasia and reduced Purkinje cell numbers being the largest neurological
commonality with regards to autism (Bauman, 1991; Courchesne, 1997; Courchesne et
al., 1994; Courchesne, Yeung-Courchesne, Press, Hesselink, & Jemigan, 1988; DiCicco
et al., 2006; Palmen, Van Engeland, Hof, & Schmitz, 2004; Whitney, Kemper, Bauman,
Rosene, & Blatt, 2008). This reduction in Purkinje cells is also present in other disorders
in the ASD spectrum, including Asperger’s and other syndromes (Hallahan et al., 2009;
McKelvey, Lambert, Mottron, & Shevell, 1995; Murakami, Courchesne Haas, Press, &
Yueng-Courchesne, 1992). MRI scans show evidence that children with autism have
decreased cerebellar volume as compared to a healthy child (Webb et al., 2009).
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Postmortem studies show clear reductions in the size and number of cells in the deep
cerebellar nuclei (dentate nucleus, DN), an area commonly associated with the cognitive
functions of the cerebellum (Bauman & Kemper, 2005; Bailey et al., 1998; Vargas,
Nascimbene, Krishnan, Zimmerman, & Pardo, 2005).
Autism Disconnection Hypothesis
Current and previous research implicates that cerebellar abnormalities are likely a
precursor to the complicated interaction of genetic predisposition and environmental
diathesis or stressors, in developing autism. Cerebellar output could be deregulated
ultimately transitioning into the behavioral and cognitive symptoms of autism or ASD.
The autism disconnection hypothesis states that there is some form of a division in the
autistic brain due to cerebellar neuropathology and more specifically reduction in
Purkinje cells (Amaral, Schumann, & Nordahl, 2008; Palmen et al., 2004; Whitney et al.,
2008). The disconnection in cerebellar output is likely producing some form of
impairment in neural circuitry that elicits impaired cognitive and behavioral functionality.
Evidence of such neuronal circuitry have been shown by Middleton and Strick
(2000), by use of retrograde transportation of the herpes simplex virus to trace multiple
closed-loop, basal ganglia and cerebellar-cortical circuits that project via the thalamus to
the prefrontal cortex (PFC), an area known to be involved in cognitive functions such as
memory, planning and decision making (Middleton & Strick, 2000, Schmahmann, 2001).
It has also been shown that there are clear cerebellar projections to the ventral tegmental
area (VTA) which encompasses the mesocortical dopaminergic system that terminates in
the PFC (Fallon & Moore, 1978). Both of these neuronal circuits have major influences
on dopamine in the PFC and glutamate throughout the entire circuit (Rogers et al., 2011).
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Due to the major role that the PFC plays in cognitive functions, it is evident that any
disruption or disconnection along either of these cerebellar-PFC pathways would likely
result in cognitive shortfalls. Shortfalls commonly present in autism and ASD.
The proposed neuronal circuitry of cerebellar influence on PFC, based on
discussed findings, is illustrated in Figure 1. Both of these neuronal circuits originate in
cerebellar cortex Purkinje neurons that project to the dentate (DN). The cerebellar-ventral
tegmental-cortical circuit involves indirect activation of mesocortical dopaminergic
neurons via contralateral projections of the DN to reticulo-tegmental nuclei (RTN) that,
in turn, project to pedunculopontine nuclei (PPT) and then project to, and stimulate
directly, VTA dopaminergic cell bodies projecting to the medial PFC (mPFC)
(Mittleman, Goldowitz, Heck, & Blaha, 2008; Perciavalle, Berretta, & Raffaele, 1989;
Rogers et al., 2011; Schwarz & Schmitz, 1997; Snider, Maiti, & Snider, 1976). The
cerebello-thalamocortical circuit involves activation of the contralateral projections of the
DN to thalamic mediodorsal/ventrolateral nuclei (ThN md/vl) that send afferents to the
mPFC to modulate mesocortical dopaminergic terminal release in the mPFC via
appositional excitatory glutamatergic synapses (see Figure 1) (Del Arco & Mora, 2005;
Middleton & Strick, 2001; Mittleman et al., 2008; Pinto, Jankowski, & Sesack, 2003;
Carper & Courchesne, 2005; Tsantsani et al., 2003). Considered together, this research
suggests that changes in either or both of these circuits could result in aberrant
glutamatergic and or dopaminergic activity in the PFC.
A potential disconnection occurring between the cerebellum and PFC in autism
would implicate abnormalities structurally and/or functionally in some if not all loci
along the affected circuit. Previous research has indicated that structural abnormalities in
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the PFC are present in individuals with autism, primarily consisting of an enlarged frontal
cortex, which has been positively correlated with autistic symptoms (Sivaswamy et al.,
2010; Yu, Cheung, Chua, & McAlonan, 2011). Both positron emission tomography and
fMRI studies exhibit abnormal medial PFC (mPFC) activity in individuals with autism
while performing cognitive tasks (Castelli, Frith, Happe, & Frith, 2002; Gilbert,
Meuwese, Towgood, Frith, & Burgess, 2009; ; Luna et al., 2002; Wang, Lee, Sigman, &
Dapretto, 2007; Wong, Fung, Chua, & McAlonan, 2008). MRI studies have also shown
that there are correlations in reduced thalamic volume in individuals with autism as
compared to healthy individuals (Estes et al., 2011; Tamura, Kitamaura, Endo,
Hasegawa, & Someya, 2010). Activation levels, when performing cognitive tasks, in the
medial thalamus have also been seen to show discrepancies between healthy individuals
and individuals with autism (Takarae, Minshew, Luna, & Sweeney, 2007).
With known aberrations in the cerebello-PFC due to either a reduction in or
dysfunction of Purkinje cells in the cerebellum, allows for animal models to mimic such
physiological abnormalities for study. One such mouse strain is the Lurcher mutant
mouse. Lurcher mutant (Lc+) mice have an autosomal dominant mutation that causes
outright loss of almost all Purkinje cells between the 2nd and 4th weeks of life (Caddy &
Biscoe, 1979; Goodrich-Hunsaker et al., 2011). Behaviorally these mice are ataxic and
exhibit distinct lurching movements, chimeric mice (Lc/+ ↔ +/+), mice that have a
variable loss of Purkinje cells, as dependent on the breeding methods with wildtype
control lurchers, are used to examine the behavioral impact of Purkinje cell loss
(Goldowitz, Moran, & Wetts, 1992). Lurcher mice exhibit deficits in executive function
when presented with serial reversal learning tasks; the number of Purkinje cells is
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negatively correlated with learning errors on such described tasks (Dickson et al., 2010).
Difficulty completing mazes, as well as increases in repetitive behaviors have all been
seen in Lurcher mutant mice (Belzung, Chapillon, & Lalonde, 2001; Martin, Goldowitz,
& Mittleman, 2010).
Recent research in Lurcher mice has explored the cerebello-thalamocortical and
cerebello-ventral tegmental-cortical circuits. The first pathway involves activation of
contralateral glutamatergic projections of the DN to ThN md and ThN vl that then send
glutamatergic efferents to the mPFC to modulate mesocortical dopaminergic release
(Middleton & Strick, 2000; Middleton & Strick, 2001; Pinto et al., 2003; Pirot, Jay,
Glowinski, & Thierry, 1994). The second pathway involves indirect activation of
mesocortical dopaminergic neurons in the VTA via contralateral glutamatergic
projections of the DN to the RTN that, in turn, project to PPT, that then project to, and
stimulate directly, VTA dopaminergic cell bodies that project to the mPFC (Lavoie &
Parent, 1994; Oakman, Faris, Cozzari, & Hartman, 1999; Schwarz & Schmitz, 1997;
Vertes, Martin, & Waltzer, 1986). Mittleman and colleagues (2008), used fixed potential
amperometry (FPA) to detect dopamine release in the PFC following electrical
stimulation of the cerebellar Purkinje cell layer or dentate nucleus (DN) of the cerebellum
in mice. Lurcher mutant mice with significant Purkinje cell loss produced significantly
different levels of dopamine release as compared to a normal control littermate. Rogers
and colleagues (2011), examined both neuronal circuits by means of FPA to explore DN
stimulation-evoked dopamine release in the PFC of mice pre and post infusions of local
anesthetic (lidocaine) and a broad spectrum glutamate ionotropic receptor antagonist
(kynurenate), into the VTA, as well as md or vl aspects of the thalamus. Infusions of both
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lidocaine and kynurenate into the VTA produced a considerable decrease in dentate
stimulation-evoke PFC dopamine release. Similar reductions (~50%) were seen after
infusion in the thalamus. Rogers and colleagues show here that there appears to be an
almost even distribution of cerebello-PFC circuit influence by ways of the VTA and
thalamus. Despite the Lurcher mutant strain not explicitly exhibiting genetic similarities
to autism, the neuropathological abnormalities associated with the loss of cerebellar
Purkinje cells produces autistic-like symptomatology, of which potentially includes
dysregulation of PFC dopamine release.
As projections from the DN to the thalamic nuclei and VTA are entirely
glutamatergic, it is plausible that aberrations in the functionality of glutamate are eliciting
a reduction in mPFC-evoked dopamine release. Specifically it is possible that only the
first-order projections from the DN to the RTN, and the DN to ThN md and ThN vl are
affected, or alternatively glutamatergic responsiveness encompasses the PPT and VTA to
varying extents. The purpose of the current study was to distinguish between these
possibilities. Due to this we evaluated glutamate release in the RTN, PPT and VTA
(cerebello-ventral tegmental pathway), as well as the ThN md and ThN vl (cerebellothalmocortical pathway) evoked by localized electrical stimulation using FPA in
combination with glutamate enzyme-based recording probes in urethane-anesthetized
Lurcher wildtype and mutant mice to distinguish potential differences.
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Methods
Experimental subjects were bred and maintained in the Animal Care Facility
located in the Department of Psychology at the University of Memphis. Mice were
continuously maintained in a temperature-controlled environment (21±1 °C) on a 12:12
light/dark cycle (lights on at 0800) and were given free access to food and water. Original
Lurcher (#001046) breeders were purchased from The Jackson Laboratory (Bar Harbor,
Maine). All experiments were approved by a local Institutional Animal Care and Use
Committee and conducted in accordance with the National Institutes of Health Guidelines
for the Care and Use of Laboratory Animals.
To produce Lurcher mutant (Lc+) mice, ataxic male mice heterozygous for the
Lurcher spontaneous mutation (B6CBACa Aw-J/A-Grid2Lc) were bred with non-ataxic
female wildtype (WT) mice (B6CBACa Aw-J/A-Grid2+). This breeding strategy
produced litters composed of both heterozygous mutant and WT mice. Due to their ataxic
gait, mice heterozygous for the Lurcher mutation are easily distinguishable from their
non-ataxic WT littermates.
A total of 61 adult male Lc+ or WT mice were used. 6 Lc+ and 3 WT mice were
used for the assays in the ThN md, 6 Lc+ and 6 WT mice for the ThN vl, 10 Lc+ and 10
WT mice for the RTN, 7 Lc+ and 4 WT mice for the VTA, and 4 Lc+ and 5 WT mice for
the PPT. All were urethane-anesthetized (1.5 g/kg i.p.) and placed in a stereotaxic frame.
Body temperature was maintained at 36±0.5 °C with a temperature-regulated heating pad.
Fixed-potential amperometry (FPA) was used with a concentric bipolar stimulating
electrode (SNE-100, Kopf Instruments) and a glutamate enzyme recording probe (model
7001, Pinnacle Technology), with an Ag/AgCl reference electrode component. As
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depicted in Figure 2, in individual mice, an electrode was implanted adjacent to the
stimulating electrode in the left hemisphere using coordinates with respect to bregma and
depth with respect to dura, in either the ThN md
(AP −1.35, ML +0.4, and DV −2.75), ThN vl (AP −1.35, ML + 1.0, and DV −3.45), RTN
(AP −4.6, ML +0.3, and DV −4.3), PPT (AP −4.7, ML +1.2, and DV −2.75), or the VTA
(AP −3.3, ML +0.35, and DV −4.0). Figure 1 indicates the stimulation/recording sites.
Electrical stimulation and FPA coupled with glutamate enzyme-based recording
probes has been shown to be a valid technique for real-time monitoring of stimulationevoked glutamate release (Agnesi, Blaha, Lin, & Lee, 2010; Agnesi et al., 2009). Briefly,
all glutamate recording probes were calibrated in a flow cell using glutamate solutions
(10–400 μM) prior to insertion in the brain. A stock solution of L-glutamic acid
(monosodium salt hydrate) and saline was freshly prepared prior to each probe
calibration. Five separate concentration steps (10, 50, 100, 200, and 400 μM) were
injected sequentially through the flow cell over the recording probe. As in vivo, a fixed
positive potential (+0.6 V) was applied to the recording probe and oxidation current was
monitored continuously. Linear glutamate concentration–oxidation current correlation
coefficients equal to or greater than 0.97 were deemed acceptable. Individual probe
calibration values were used to establish glutamate concentrations recorded in vivo. All
recording sites were taken from The mouse brain in stereotaxic coordinates 2nd ed
(Paxinos & Franklin, 2001). A fixed positive potential (+0.6 V) was applied to the
recording electrode and oxidation current was monitored continuously (10 K samples/s)
by an electrometer filtered at 50 Hz. A total of three stimulations (100 monophasic 0.5
ms duration pulses at 100 Hz every 600 s) were applied to the ThN md, ThN vl, RTN,
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PPT, or VTA (at 800 μAmps). As reviewed recently by Tehovnik (1988), the spread of
effective current is proportional to the square of the distance between the electrode tip
and is highly dependent on the pulse duration and current–distance constant of neurons
(low vs. high excitability threshold). Current–distance constants typically range from 100
to 4,000 μAmps/mm2 in brain tissue. Myelinated axons such as glutamatergic fibers
exhibit a relatively high current–distance constant of 2,000–4,000 μAmps/mm2 (Zuo et
al., 1997). Thus, for high-threshold neurons (~3,500 μAmps/mm2), we estimate that 0.5
ms pulses at 800 μAmps would activate these neuronal elements ~0.6 mm from the
electrode tip. Six hundred seconds after the final stimulation the glutamate probe was
withdrawn from the brain and a bipolar stimulating electrode was introduced into the
same location. A direct current (100 μAmps for 10 s) was passed through this electrode to
lesion the stimulation/recording site.
Data Analysis
Based upon probe calibration, oxidation current following each of the three
stimulations was converted to evoked glutamate concentration (micromoles) at 5 s
intervals ranging from 0 to 240 s post-stimulation. The initial mixed model analysis of
variance involved four factors. Between-subjects factors included Site (ThN md, ThN vl,
RTN, PPT and VTA) and Group (WT or Lc+), while Stimulation (1, 2, 3) and Time (0 to
240 s in 5 s intervals) were the within-subjects factors. Results of this initial, omnibus
ANOVA necessitated additional three factor ANOVAs restricted to each stimulation site.
When appropriate, between-group differences were further analyzed using simple main
effects tests or Dunnett's t tests.
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Results
Histology
Immediately following each experiment each mouse was euthanized with a lethal
intracardial injection of urethane. Brains were removed and preserved in 10 % buffered
formalin containing 0.1 % potassium ferricyanide, and then stored in 30 % sucrose/ 10 %
formalin until sectioning. The brains were sectioned on a cryostat at −30 °C. A Prussian
blue spot indicative of the redox reaction of ferricyanide and iron deposits labeled the
stimulating electrode tip in each stimulation/recording site. As shown in Figure 3,
stimulation/recording sites were localized to the target sites. The ranges in localized
histology were, in millimeter, (AP −1.22 to −1.46, ML 0.25 to 0.75, DV −2.5 to −3.25;
AP −1.06 to −1.46, ML 0.75 to 1.25, DV −3.25 to −3.75; AP −4.48 to −4.72, ML 0.20 to
0.75, DV −4.0 to −4.6; AP −4.48 to −4.72, ML 0.75 to 1.25, DV −2.5 to −3.25; and AP
−3.08 to −3.4, ML 0.2 to 0.6, DV −3.75 to −4.25) for the ThN md, ThN vl, RTN, PPT,
and VTA respectively.
The omnibus ANOVA indicated that significant differences occurred as a
function of stimulation Site (Site: F = 3.44, df = 4.51, p < 0.02) and Group (Group: F =
8.44, df = 1.51, p = 0.005), and that group differences in the time course of evoked
glutamate release occurred as a function of Site and Stimulation number
(Site×Stimulation: F = 1.97, df = 384,4752, p < 0.001). Thus, each Site was subsequently
analyzed separately. As shown in Figure 4, WT mice had significantly greater evoked
glutamate release in the ThN md in comparison to Lc+ animals (Group×Time: F = 15.4,
df = 48,336, p < 0.001). Dunnett's t tests further indicate that groups differed significantly
between 5 and 90 s post-stimulation. A similar pattern was observed in response to
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electrical stimulation of the ThN vl (Group×Time: F = 3.67, df = 48,480, p < 0.001),
although the significantly increased glutamate release in WT mice persisted for up to 100
s post-stimulation (Dunnett's t test). Lc+ and WT mice also differed significantly in
evoked glutamate release in the RTN (Group×Time: F = 5.06, df = 48,864, p < 0.001),
although this difference was shorter in duration and occurred from 5 to 70 s poststimulation (Dunnett's t test). Group differences in evoked glutamate release were
somewhat smaller in the PPT (Group×Time: F = 2.29, df = 48,336, p < 0.001) and were
apparent between 10 and 45 s post-stimulation (Dunnett's t test). As shown in Figure 4,
evoked glutamate release in WT and Lc+ mice was comparable following stimulation of
the VTA (Group×Time: F = 0.5, df = 48,432, p = ns). Figure 5 shows the micromolar
evoked glutamate release averaged across three stimulations over the 240 s recording
intervals at each recording site in WT and Lc+ mice. As can be seen in figure 5, Lc+
mice had the largest reductions in glutamate release in ThN md, ThN vl, and RTN.
A number of different patterns of response were apparent over successive
stimulations. The average amount of evoked glutamate release was maintained in WT
and Lc+ animals following repeated electrical stimulations in the ThN md (Stimulation: F
= 0.54, df = 2,14, p = ns), RTN (Stimulation: F = 0.19, df = 2,34, p = ns), or PPT
(Stimulation: F = 2.30, df = 2,14, p = ns). In the ThN vl, there was a group difference in
evoked glutamate release (Group × Stimulation: F = 3.95, df = 2,19, p < 0.05). Simple
main effects tests revealed that in WT mice, glutamate release increased significantly
during the second and third stimulations in comparison to the first (Stimulation: F = 4.67,
df = 2,10, p < 0.05). In contrast, in the ThN vl, glutamate release declined significantly
across stimulations in Lc+ animals (F = 4.41, df = 2,9, p < 0.05). In the VTA, there was a
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small but significant increase in evoked glutamate release across the three stimulations in
both WT and Lc+ mice (Stimulation: F = 3.97, df = 2, 18, p < 0.05).
Discussion
The present results show that localized electrical stimulation of glutamatergic
axons in the ThN md, ThN vl, RTN, and PPT of Lc+ mice resulted in significantly less
evoked glutamate release as compared to WT control mice (Figure 4). Evoked glutamate
release was equivalent in the VTA of both genotypes. These results are consistent with
the idea that both first- and second-order glutamatergic projections from the DN are
abnormal in Lc+ mice, a strain that possess developmental cerebellar neuropathology by
means of decreased cerebellar Purkinje cells (Caddy & Biscoe, 1979; Zuo et al., 1997). It
is highly likely that it is this cerebellar neuropathology that produces the subsequent
reduction in glutamate release observed in cerebellar efferents from the DN. Both
pathways are involved in the modulation of mPFC dopamine release, making it plausible
that the observed reductions in glutamate release account for diminished mPFC dopamine
release elicited by electrical stimulation of the DN in Lc+, compared to WT mice
(Mittleman et al., 2008).
It is important to note that observed reductions in glutamate release in cerebellar
efferent pathways could result from at least two different sources. As a function of loss of
Purkinje cells in the cerebellar cortex causing subsequent reductions in inputs to the DN,
and/or possible reductions in the population of glutamatergic efferents, corresponding to
reductions in glutamate available for release. In concordance with the second possible
source, reductions in glutamate release have been shown to correlate with reductions in
the numbers of activated glutamatergic neurons in vivo. The concentration of glutamate
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immunoreactivity and the concentration of glutamate neurons corresponded to associated
glutamate evoked neuronal activity in studies of the visual cortex in monkeys and cats
(Arckens et al., 2000; Carder & Hendry, 1994). In schizophrenia, another disorder where
diverse symptomatology that has been suggested to result from developmental
abnormalities in prefrontal cortico-cerebellar-thalamo-prefrontal cortical circuits,
cerebellar abnormalities including reductions in cerebellar Purkinje cells have also been
observed (Andreasen, Paradiso, & O’Leary, 1998; Kyriakopoulos, Vyas, Barker, Chitnis,
& Frangou, 2008; Maloku et al., 2010). Diffusion tensor imaging in schizophrenics has
revealed reduced anistropic diffusion in connectivity between cerebellum and thalamus,
which was interpreted as a loss of connectivity (Magnotta et al., 2008). It seems possible
that reductions in the population of glutamatergic efferents from the DN to the thalamus,
including the RTN and its projections to the PPT, could contribute to a loss in
connectivity and drive. Quantitative morphological analysis of deep cerebellar nuclei
have shown a 20 % and 37 % reduction in the number of principal and small neurons,
respectively, in the DN of adult Lc+ mice as a result of secondary transneuronal
degeneration brought on by the developmental loss of cerebellar Purkinje cells (Heckroth,
1994). In addition, volumetric analysis has shown the loss of myelinated axons and
boutons accounts for 59 % of the atrophy of the DN in Lc+ mice, with the remaining 41
% accounted for by a loss in nuclear neurons, dendritic arbors and reduced volume of
glial processes, vascular elements, and intercellular space (Strazielle, Lalonde, & Reader,
2000).
Alternatively, as a function of loss of Purkinje cells in the cerebellar cortex and
subsequent reductions in impulse traffic to the DN, glutamatergic receptors and cellular
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machinery contributing to the processes of synthesis and release may be altered, resulting
in a reduction in glutamatergic transmission and glutamate available for release. For
example, autoradiography of glutamate receptor binding in adult Lc+ mice, compared to
WT mice, has shown a significant decrease in ionotropic glutamatergic receptors in the
DN, as well as in the thalamus, neostriatum, limbic regions, and cerebral cortical regions
(Strazielle, et al., 2000). As shown in Figure 6, glutamate can be enzymatically
synthesized in the mitochondria from glutamine by glutaminase 1 (Gls1 gene products)
and then transported into presynaptic vesicles via transporters Vglut1/2 (Slc17a7 and
Slc17a6 gene products) or further metabolized to α-ketoglutarate by glutamate
dehydrogenase (Glud1 gene product) as part of cellular metabolism. During synaptic
transmission, glutamate can bind to a number of ionotropic (NMDA and AMPA/kainate)
and group I metabotropic (mGluR1/5) receptors in the postsynaptic cell, as well as group
II (mGluR2/3) and group III (mGluR4, 6–8) metabotropic receptors in the presynaptic
terminal. For instance, glutamate neurotransmission is inhibited by activation of group I
and II metabotropic receptors resulting in a down regulation of postsynaptic glutamate
response or presynaptic glutamate release, respectively. In addition, glutamate is removed
from the synaptic cleft by glial transporters EAAT1/ Glt2 (Slc1a3 gene product) and
EAAT2/GLAST (Slc1a2 gene product). In astrocytes, glutamate is converted to
glutamine and transported out by SN1, where it can be taken up by neurons via GLNT
and SAT2, and where it is converted back to glutamate by mitochondrial glutaminase
(GLS1) in order to replenish the vesicular glutamate pool in the presynaptic terminal.
Astrocytes also contain glutamate decarboxylase (GAD) that enzymatically converts
glutamate to GABA (Lee, Schwab, & McGeer, 2011). Thus, a reduction in glutamate
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stores could arise from multiple intraneuronal or astrocytic metabolic pathways including
an up regulation of astrocytic GAD activity. For example, Shimmura and colleagues
(2013), examined the anterior cingulate cortex and found that the protein levels of
kidney-type glutaminase, but not those of the other enzymes, were significantly lower in
subjects with autism compared to controls. In addition, using proton magnetic resonance
spectroscopy in two brain regions implicated in ASD (the basal ganglia and prefrontal
cortex), investigators have recently shown marked reductions in glutamate, and glutamine
in autistic patients (Horder et al., 2013). Thus, it is conceivable that glutamate synthesis,
and thus tissue content, may be diminished in astrocytes and/or glutamatergic terminals
in first- and second-order glutamatergic projections from the DN in Lc+ mice resulting in
an overall reduction in stimulation-evoked glutamate release.
We suspect that mechanisms involving reductions in the population of
glutamatergic efferents, as well as reductions in the processes governing synthesis and
release are reflected in Lc+ mice. Specifically, in Lc+ mice in the ThN md, RTN, and
PPT we found clear evidence of reductions in evoked glutamate release that were
maintained across successive stimulations. We believe this pattern of results is indicative
of a reduction in the population of glutamatergic axons in these nuclei. In contrast,
evoked glutamate release in Lc+ mice was lower than that of WT mice, and additionally
declined significantly with repeated stimulation in the ThN vl. It seems reasonable that
this pattern of change is additionally indicative of alterations in the processes contributing
to synthesis and release as well as reduced numbers of glutamatergic axons projecting to
this nucleus. It should be noted that relatively little is known about glutamatergic
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projections from the DN to thalamic and brainstem nuclei in Lc+ mice or ASD. Thus,
further investigation of these possibilities is warranted.
Future directions
Autism has certainly been a topic of extremely hot debate as of recent. The
prevalence rates, relative to other neurodevelopmental disorders are increasing at an
alarming rate, due to a variety of possible causes; gross increase in cases, more
comprehensive diagnostic methodology, or a variety of other factors. However, there is
still little understanding about both the etiology and treatment of autism and other
disorders that fall within the spectrum of ASD. One of the largest limitations of treatment
is a lack of pharmacological strategies, primarily due to a very limited understanding of
the neuropathology of the disorder. The present findings supplement previous findings
that both the cerebello-thalamocortical and cerebello-ventral tegmental-cortical circuits
influence cerebellar modulation of glutamatergic and dopaminergic inputs. A modulation
that is the result of absent and dysfunctional Purkinje cells in the cerebellum. With more
comprehensive understanding of this influence from the cerebellar Purkinje cells it is
possible to further explore and better understand the neuropathology of the diminished
cognitive abilities present in autism.
From this, a plethora of potential treatment options would be readily available.
Treatments from pharmacological strategies that target dysfunctional neurotransmitter
release, to deep brain stimulation methods in the cerebellum or other nuclei, to
corticosteroids that may influence an autoimmune response, to viral vectors having the
capability of specifically modulating genetic predispositions, to countless other
therapeutic techniques. However, long before any of these therapeutic attempts are
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trialed, a further and more complete understanding of where, why and how cerebellar
Purkinje cells, as well as other factors along the cerebellar-cortical circuitry, influence the
neuropathological expression of autism.
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Appendix

Figure 1. Neuronal circuitry underlying cerebellar modulation of medial prefrontal cortex
(mPFC) dopamine neurotransmission. Cerebellar modulation of dopamine release in the
mPFC may occur via polysynaptic inputs from deep cerebellar nuclei, such as the dentate
nucleus, to dopamine-containing cells in the ventral tegmental area or via a monosynaptic
input to thalamic (md, mediodorsal; vl, ventrolateral) projections making close
appositions with dopamine terminals in the mPFC. Glutamatergic pathways are shown as
gray arrows and the dopaminergic pathway as a dashed arrow. Black curved arrow
represents mPFC feedback to cerebellum via pontine nuclei. Gray ovals correspond to
stimulation-evoked glutamate recording sites. Nuclei abbreviations are shown in the
ovals.
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Figure 2. Experimental design to evaluate effects of synaptic stimulation-evoked Glu
release in the ThN md, ThN vl, or VTA.
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Figure 3. Representative coronal sections in Lurcher (Lc+) and wildtype (WT) mice
illustrating placements (gray shaded areas) of stimulation/recording electrodes in the
mediodorsal nucleus of the thalamus (ThN md), ventrolateral nucleus of the thalamus
(ThN vl), reticulotegmental nucleus (RTN), pedunculopontine nuclei (PPT), and ventral
tegmental area (VTA). Numbers correspond to mm from bregma. Placements of
stimulating/recording overlapped in all groups. Sections were adapted from the mouse
atlas of Franklin and Paxinos, (2001).
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Figure 4. The time-course of glutamate release evoked by electrical stimulation of the
mediodorsal nucleus of the thalamus (ThN md), ventrolateral nucleus of the thalamus
(ThN vl), reticulotegmental nucleus (RTN), pedunculopontine nuclei (PPT), or ventral
tegmental area (VTA) in Lurcher (Lc+) mutant mice or wildtype (WT) controls. A total
of 3 stimulations (100 monophasic 0.5 msec duration pulses at 100 Hz every 600 secs)
were applied to the ThN md, ThN vl, RTN, PPT, or VTA (at 800 µAmps). Results
averaged across the 3 stimulations are shown. Vertical lines indicate the standard error of
the mean.
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Figure 5. Average glutamate release evoked
by electrical stimulation of the mediodorsal
nucleus of the thalamus (ThN md),
ventrolateral nucleus of the thalamus (ThN
vl), reticulotegmental nucleus (RTN),
pedunculopontine nuclei (PPT), or ventral
tegmental area (VTA) in Lucher (Lc+)
mutant mice or wildtype (WT) controls. A
total of 3 stimulations (100 monophasic 0.5
msec duration pulses at 100 Hz every 600
secs at 800 µAmps) were applied to each
stimulation/recording site. Results of each
stimulation are shown. Vertical lines
indicate the standard error of the mean. * p
< 0.05 successive stimulations vs. first
stimulation in WT and Lc+ mice.
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Figure 6. Schematic representation of glutamate release at cerebellar synaptic junctions.
Glutamate (glu) released from pre-synaptic glutamatergic neurons acts on post-synaptic
and presynaptic neuronal metabotropic and ionotropic (NMDA and AMPA) receptors.
See text for details. VGlut, vesicular glutamate transporter; mGluR, metabotropic
glutamate receptors; AMPA, α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
NMDA, N-methyl-D-aspartate; EAAT, excitatory amino acid transporter; GAD,
glutamate decarboxylase; GABA, -aminobutyric acid; SN1, glutamine transporter;
SAT2, system amino acid transporter; GLNT, neutral amino acid transporter; GLS,
glutaminase; GLUD1, glutamate dehydrogenase.
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Your protocol is not approved for the following reasons (see attached memo).
Your protocol is renewed without changes for the following period:
From:

To:

Your protocol is renewed with the changes described in your IACUC Animal Research
Protocol
Revision Memorandum dated for the following period:
From:

To:

Your protocol is not renewed and the animals have been properly disposed of as
described in your IACUC Animal Research Protocol Revision Memorandum dated
___________________________________________
Prof. Guy Mittleman, Chair of the IACUC
___________________________________________
Dr. Karyl Buddington, University Veterinarian
And Director of the Animal Care Facilities
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